✦ LIBER ✦

Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine

✍ Scribed by Jun Zhang; Chong-bo Liu; Rong-cheng Li; Yi-min Li; Ying-jie Zheng; Yan-ping Li; Dong Luo; Bai-bin Pan; Yi Nong; Sheng-Xiang Ge; Jun-hui Xiong; James Wai-kuo Shih; Mun-Hon Ng; Ning-shao Xia

Book ID: 116961243
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 525 KB
Volume: 27
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2008.12.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-clinical immunogenicity and efficacy

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine

✍ Robert H Purcell; Hanh Nguyen; Max Shapiro; Ronald E Engle; Sugantha Govindaraja 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Niccine(R), a Nicotine Vaccine, for Rela

Niccine(R), a Nicotine Vaccine, for Relapse Prevention: A Phase II, Randomized, Placebo-Controlled, Multicenter Clinical Trial

✍ Tonstad, Serena (author);Heggen, Eli (author);Giljam, Hans (author);Lagerbäck, P 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 915 KB

Niccine(R), a Nicotine Vaccine, for Rela

Niccine(R), a Nicotine Vaccine, for Relapse Prevention: A Phase II, Randomized, Placebo-Controlled, Multicenter Clinical Trial

✍ Tonstad, Serena (author);Heggen, Eli (author);Giljam, Hans (author);Lagerbäck, P 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 915 KB

Randomized controlled trial of recombina

Randomized controlled trial of recombinant interferon a-2b (IFN) in chronic hepatitis C

✍ Tarsetti, F.; Candelaresi, MT.; Mosca, P; Freddara, U.; Lorenzini, I.; Peruzzi, 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Double-blind, randomized, placebo-contro

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®

✍ C. Vilaplana; E. Montané; S. Pinto; A.M. Barriocanal; G. Domenech; F. Torres; P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 829 KB

Treatment of chronic hepatitis C with re

Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trial

✍ Giulio Diodati; Paola Bonetti; Franco Noventa; Carla Casarin; Massimo Rugge; Ser 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Sixty consecutive patients with chronic hepatitis C were included in a randomized controlled trial of recombinant human interferon-%, vs. no treatment. Treated patients received tapering doses of interferon thrice weekly for 1 yr. Twenty treated cases (66.7%) normalized serum aminotransferase levels